medical innovation – The Milli Chronicle

Tuesday, December 9, 2025

Latest:

Hope Endures as Kherson Residents Seek Renewal Amid Ongoing Hardship
China Calls for Stronger Global Cooperation as Record Trade Surplus Highlights New Opportunities
Lithuania Strengthens National Security Measures as Balloon Incursions Prompt Unified Response
Thailand Calls for Peaceful Dialogue and Stability in Relations With Cambodia
India Strengthens Financial Oversight as New Cases Aim to Improve Transparency and Investor Confidence

Factual Version of a Story

Latest Middle East and North Africa News

NewsDesk Milli Chronicle December 8, 2025December 8, 2025 advanced prosthetics, amputee care, children’s rehabilitation, community health, disability inclusion, health development, humanitarian program, medical innovation, Medical Outreach, mobility solutions, patient empowerment, patient support, physical therapy, prosthetic limbs, prosthetic technology, psychological therapy, rehabilitation center, rehabilitation services, Saudi initiative, social support

Rebuilding Lives Through Hope: Saudi Initiative Transforms Care for Amputees

Makkah – A growing humanitarian effort in Saudi Arabia is reshaping the lives of amputees through comprehensive medical, psychological and

Asia Latest News

NewsDesk Milli Chronicle November 7, 2025November 7, 2025 Cipla, diabetes care India, diabetes control, diabetes treatment India, Eli Lilly, Eli Lilly India, GLP-1 drugs, healthcare growth India, healthcare technology, Hyderabad health innovation, India pharma market, medical innovation, metabolic health, Mounjaro, Novo Nordisk, obesity awareness, obesity treatment, pharmaceutical sales India, Wegovy, weight management therapy, weight-loss drug India, weight-loss injection

Eli Lilly’s Mounjaro Becomes India’s Top-Selling Drug, Signaling a New Era in Healthcare Innovation

Hyderabad – Eli Lilly’s groundbreaking weight-loss and diabetes treatment, Mounjaro, takes the top spot in India’s pharmaceutical market, marking a

Featured News World

NewsDesk Milli Chronicle November 4, 2025 Center for Drug Evaluation and Research, clinical trials, drug approval process, drug safety, ethical governance, FDA ethics, FDA leadership change, FDA modernization, FDA reform, Food and Drug Administration, global drug safety, health policy, healthcare transparency, medical innovation, medical research, pharmaceutical innovation, pharmaceutical regulation, public health, Robert F. Kennedy Jr., U.S. health agencies, US FDA

US FDA’s Drug Division Undergoes Leadership Transition to Strengthen Integrity and Innovation

The U.S. Food and Drug Administration begins a new chapter in its drug evaluation and research division, focusing on ethics,